Concepedia

Doris Soebbing

DS

Statistics

Publications

4

Citations

518

H-Index

4

Active since

2017

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Nationwide Children's Hospital

Doris Soebbing is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, medicine, and cell therapy.

Publications per year

2017–2024

4

Publications

4

Phase 1 clinical trial using mbIL21 ex vivo–expanded donor-derived NK cells after haploidentical transplantation

Stefan O. Ciurea, Jolie Schafer, Roland L. Bassett et al. · Blood · 2017 · 343 citations

Pharmacy, Immunology, Translational Sciences +14

Decrease post-transplant relapse using donor-derived expanded NK-cells

Stefan O. Ciurea, Piyanuch Kongtim, Doris Soebbing et al. · Leukemia · 2021 · 104 citations · Full text

Medicine, Hematology, Immunology +17

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

Mithun Vinod Shah, Rima M. Saliba, Gabriela Rondón et al. · Bone Marrow Transplantation · 2018 · 40 citations · Full text

Medicine, Hematology, Immunology +17

Results of a phase I trial with Haploidentical <scp>mbIL</scp>‐21 ex vivo expanded <scp>NK</scp> cells for patients with multiply relapsed and refractory <scp>AML</scp>

Stefan O. Ciurea, Piyanuch Kongtim, Samer A. Srour et al. · American Journal of Hematology · 2024 · 31 citations · Full text

Medicine, Hematology, Oncology +17

1–4 of 4